D/C/F/TAF Versus COBI-boosted DRV Plus FTC/TDF in HIV-1 Infected, Antiretroviral Treatment Naive Adults
Last updated on July 2021Recruitment
- Recruitment Status
- Completed
- Estimated Enrollment
- 150
Summary
- Conditions
- Acquired Immunodeficiency Syndrome
- HIV Infections
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Double (Participant, Investigator)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT01565850
- Collaborators
- Not Provided
- Investigators
- Study Director: Moupali Das, MD, MPH Gilead Sciences
Get Well Soon